Jane Street Group LLC Has $1.58 Million Stock Position in Avanos Medical, Inc. (NYSE:AVNS)

Jane Street Group LLC lifted its holdings in Avanos Medical, Inc. (NYSE:AVNS) by 35.8% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 65,650 shares of the company’s stock after acquiring an additional 17,306 shares during the period. Jane Street Group LLC owned approximately 0.14% of Avanos Medical worth $1,578,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of AVNS. Quarry LP bought a new stake in shares of Avanos Medical during the 3rd quarter valued at $42,000. Atom Investors LP acquired a new position in Avanos Medical in the third quarter valued at about $210,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Avanos Medical by 12.0% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 108,470 shares of the company’s stock valued at $2,607,000 after purchasing an additional 11,613 shares in the last quarter. FMR LLC lifted its position in Avanos Medical by 34.6% during the third quarter. FMR LLC now owns 133,844 shares of the company’s stock worth $3,216,000 after purchasing an additional 34,421 shares during the period. Finally, The Manufacturers Life Insurance Company grew its stake in Avanos Medical by 34.2% during the third quarter. The Manufacturers Life Insurance Company now owns 22,996 shares of the company’s stock worth $553,000 after buying an additional 5,859 shares in the last quarter. 95.17% of the stock is owned by institutional investors.

Avanos Medical Stock Performance

Avanos Medical stock opened at $16.16 on Friday. The business has a 50 day moving average of $19.29 and a 200-day moving average of $21.23. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46. Avanos Medical, Inc. has a 1 year low of $15.85 and a 1 year high of $25.36. The company has a market capitalization of $742.67 million, a P/E ratio of 47.53 and a beta of 0.95.

Analysts Set New Price Targets

Separately, StockNews.com downgraded shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.